Pharvaris BV share price logo

Pharvaris BV

NASDAQ: PHVS

Mid Cap

$32.94

+1.69

(+5.41%)

as on

Pharvaris BV Stock Performance

as on May 14, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $31.22
    $33.12
    downward going graph

    5.22%

    Downside

    0.55%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $14.59
    $31.65
    downward going graph

    55.72%

    Downside

    -3.92%

    Upside

    downward going graph

Pharvaris BV share price movements today

Previous Close
$31.25
Open
$31.34
Volume
445.6K
Day's Low - High
$31.22 - $33.12
52 Week Low - High
$14.59 - $31.65

Pharvaris BV Historical Returns

1 Month Return
+ 8.96 %
3 Month Return
+ 18.15 %
1 Year Return
+ 94.46 %
3 Year Return
+ 290.62 %
5 Year Return
+ 46.3 %

Pharvaris BV Stock Fundamentals & Key Indicators

Check Pharvaris BV market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1B

EPS (TTM)

-2.9015

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-169.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-65.19%

Pharvaris BV vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pharvaris BV with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Pharvaris BV image
Pharvaris BV
BUY$2.1B46.3%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$38.0B115.2%71.3912.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.7BNA71.448.94%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.4B106.5%25.8435.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$74.7B40.03%17.3929.65%

Stock Returns calculator for Pharvaris BV Stock including INR - Dollar returns

The Pharvaris BV stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Pharvaris BV investment value today

Current value as on today

₹2,30,050

Returns

₹1,30,050

(+130.05%)

Returns from Pharvaris BV Stock

₹1,04,978 (+104.98%)

Dollar Impact

₹25,072 (+25.07%)

Analyst Recommendation on Pharvaris BV Stock

Based on 13 analysts

BUY

84.62%

Buy

7.69%

Hold

7.69%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Pharvaris BV. Average target price of $46.82

Pharvaris BV Share Price Target

Get share price movements and forecasts by analysts on Pharvaris BV.

What analysts predicted

29.65%UPSIDE

Target Price

$46.82

Current Price

$32.94

Analyzed by

13 Analysts

Target

$46.82

Pharvaris BV target price $46.82, a slight upside of 29.65% compared to current price of $32.94. According to 13 analysts rating.

Indian Investors' Interest in Pharvaris BV Stock

Search interest for Pharvaris BV Stock has increased by 383% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:383% versus previous 30 day period

Pharvaris BV Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
-
-
0
-
-
-
Operating Income
-27
-28
-34
-37
-45
42
-40
-39
-47
EBITDA
-
-28
-34
-37
-
-42
-40
-37
-
Interest Expense
-
0
2
0
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-31
-27
-29
-41
-33
-46
-45
-37
-45
Income Tax Expense
-
0
0
0
-
0
0
0
-
Net Income
-35
-30
-31
-46
-36
-50
-45
-37
-46
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Pharvaris BV Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
0
0
0
-
-
Operating Income
-4
-8
-28
-54
-86
-96
-145
-169
EBITDA
-4
-8
-29
-54
-86
-96
-145
-169
Interest Expense
-
0
0
0
0
0
-
-
Depreciation
-
0
0
0
0
0
0
0
Income Before Tax
-4
-8
-29
-42
-75
-99
-132
-173
Income Tax Expense
0
0
0
0
0
1
1
1
Net Income
-4
-9
-36
-48
-80
-110
-140
-175
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Pharvaris BV Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-27
-29
-41
-34
-46
-45
-37
-46
-45
Operating Cash Flow
-24
-27
-33
-34
-38
-29
-30
-37
-37
Investing Cash Flow
0
0
0
-
0
0
0
-
0
Financing Cash Flow
0
0
0
0
0
0
160
0
0
Change in Cash
-22
-24
-38
-34
-44
-36
129
-37
-37

Pharvaris BV Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-8
-26
-42
-75
-99
-132
-173
Operating Cash Flow
-6
-21
-44
-67
-93
-120
-137
Investing Cash Flow
0
0
0
0
0
0
0
Financing Cash Flow
21
101
143
8
325
2
160
Change in Cash
14
78
110
-47
229
-110
10

Global Institutional Holdings in Pharvaris BV

Funds
Holdings
The Goldman Sachs Group Inc
0.25%
AllianceBernstein L.P.
0.01%
State Street Corp
0.25%
Northern Trust Corp
0.12%
PSP Research LLC
0.03%
See all

Insights on Pharvaris BV

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, PHVS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PHVS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, PHVS stock has moved up by 290.6%

About Pharvaris BV

Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
OrganisationPharvaris BV
HeadquartersGrafenauweg 8, Zug, Switzerland, 6300
IndustryBiotechnology
CEOMr. Berndt Axel Edvard Modig CPA, M.B.A.
E-voting on sharesClick here to vote

Key Management of Pharvaris BV

Name

Title

Dr. Peng Lu M.D., Ph.D.

Chief Medical Officer

Maryann Cimino

Director of Corporate Relations

Dr. Anne A. Lesage Ph.D.

Chief Early Development Officer

Mr. Wim Souverijns Ph.D.

Chief Commercial Officer

Mr. Berndt Axel Edvard Modig CPA, M.B.A.

Co-Founder, CEO & Executive Director

Mr. David W. Nassif J.D.

CFO, Chief Legal Officer & Corporate Secretary

Ms. Anna Nijdam M.Sc., R.A.

Head of Strategic Finance & Principal Accounting Officer

Dr. Stefan Abele Ph.D.

Chief Technology Operations Officer

Ms. Annick Deschoolmeester

Chief Human Resources Officer

FAQs

What is Pharvaris BV share price today?

Pharvaris BV share price today is $32.94 as on at the close of the market. Pharvaris BV share today touched a day high of $33.12 and a low of $31.22.

What is the 52 week high and 52 week low for Pharvaris BV share?

Pharvaris BV share touched a 52 week high of $31.65 on and a 52 week low of $14.59 on . Pharvaris BV stock price today i.e. is closed at $32.94,which is -4.08% down from its 52 week high and 125.85% up from its 52 week low.

What is Pharvaris BV's market capitalisation today?

Pharvaris BV market capitalisation is $0.00T as on .

How to invest in Pharvaris BV Stock (PHVS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pharvaris BV on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pharvaris BV Shares that will get you 0.0455 shares as per Pharvaris BV share price of $32.94 per share as on May 14, 2026 at 8:45 am IST.

What is the minimum amount required to buy Pharvaris BV Stock (PHVS) from India?

Indian investors can start investing in Pharvaris BV (PHVS) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Pharvaris BV stock (as per the Rupee-Dollar exchange rate as on ). Based on Pharvaris BV share’s latest price of $32.94 as on May 14, 2026 at 8:45 am IST, you will get 0.3036 shares of Pharvaris BV. Learn more about fractional shares .

What are the returns that Pharvaris BV has given to Indian investors in the last 5 years?

Pharvaris BV stock has given 46.3% share price returns and 29.72% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?